Delivery Order SPE2DB24D2109-SPE2DB24FHWDF
Award Date
9/4/24
Potential Completion Date
9/5/24
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EXFORGE 10-320 MG TABLET 30S. The $3,517.59 firm-fixed-price contract has a completion date of July 30, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a wide range of medical commodities to support military treatment...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,510.64, is for the supply of EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed price, Indefinite Delivery Contract (IDC) running through January 2025. There is no set-aside designation for this award. AmerisourceBergen holds a larger $999,999,999 IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EXFORGE 10-160 MG TABLET 30S. The firm fixed price contract has a ceiling value of $1,200.60 and an ultimate completion date of August 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a comprehensive range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply EXFORGE 10-160 mg tablets. The $2,665.30 firm fixed price contract has an ultimate completion date of October 28, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of pharmaceutical products, specifically the medication EXFORGE 5-160 MG TABLET 30S. The contract has a firm fixed price structure and a ceiling value of $3,297.55. The ultimate completion date for this award is August 1, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical supplies to the U.S. federal government,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,321.60, is for the delivery of EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of EXFORGE HCT 10-320-25 MG TAB 30S, a prescription medication. The contract has a ceiling value of $3,780.26 and runs through October 16, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen, through its Corporate Office division, will be responsible for providing the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a firm fixed price ceiling value of $5,432.81 and a performance period ending on May 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,597.93 Firm Fixed Price Delivery Order contract is for the supply of EXFORGE 10-160 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of January 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,873.03, is a delivery order for the supply of EXFORGE 10-320 MG TABLET 30S medication. The award has an ultimate completion date of February 7, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...